Liver MRI is not accurate enough to definitely identify patients with iron overload.
Magnetic resonance imaging of the liver may help rule out iron overload, but is not accurate enough to definitely identify patients with the condition, according to an article published in the journal Clinical Gastroenterology and Hepatology.
Researchers from Greece sought to determine if using MRI could help identify patients with iron overload and to guide titration of chelation therapy. Their systematic review and meta-analysis was based on patients with hereditary hemochromatosis, hemoglobinopathy and myelodysplastic syndrome.
A total of 20 studies with 819 patients were chosen for the final analysis. The researchers found that sensitivity and specificity values varied greatly, ranging from 0.00 to 1.00 and from 0.50 to 1.00, respectively.
“Due to substantial heterogeneity and variable positivity thresholds, we calculated only summary receiver operating curves (and summary estimate points for studies that used the same MRI sequences). T2 spin echo and T2* gradient-recalled echo MRI sequences accurately identified patients without liver iron overload (liver iron concentration > 7 mg Fe/g dry liver weight) (negative likelihood ratios, 0.10 and 0.05 respectively),” the authors wrote. “However, these MRI sequences are less accurate in establishing a definite diagnosis of liver iron overload (positive likelihood ratio of 8.85 and 4.86 respectively).”
The authors concluded that while the MRI measurements of iron concentration in the liver may be accurate enough to rule out iron overload, the measurements were not accurate enough to definitely identify patients who may be overloaded.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.